Author:
Cao Li,Wu Ying,Liu Kai-Yu,Qi Ning-Xian,Zhang Jie,Tie Shan-Shan,Li Xuan,Tian Ping-Ping,Gu Shao-Bin
Publisher
Tsinghua University Press
Reference46 articles.
1. Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis;Clinical and Molecular Hepatology,2018
2. Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease;M. Z., Zhang, B. B., Zhao, J. N. Ni;Biomedicine & Pharmacotherapy,2019
3. Nonalcoholic fatty liver disease in Asia: Emerging perspectives;W. K., Yuen, M. F. Seto;Journal of Gastroenterology,2017
4. Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD;C., Hsu, C., Lo, M. T., Liu. Caussy;Hepatology,2018
5. Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model;T., Honda, A., Ikegami, T. Miyazaki;Journal of Clinical Biochemistry and Nutrition,2019